• Mon news: Autolus enters CAR-T race with FDA approval. FDA clears clinical hold on Novavax. AbbVie schizophrenia trial failure. Cigna not pursuing Humana. GSK leaving BIO. See more on our front page

With Dupixent leading the way, Sanofi’s taking on the 'big players' in...

Quote
cafead

cafead

Administrator
Staff member
  • cafead   May 22, 2023 at 11:52: AM
via Sanofi and Regeneron made waves when they presented data from a phase 3 trial that showed that blockbuster Dupixent could become the first biologic to treat chronic obstructive pulmonary disease (COPD) and the first new therapy for the condition in more than a decade.

article source
 




Top Bottom
Back
Quote